Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00330278 · ClinicalTrials.gov registry record · NA
Timing of Prophylactic Antibiotics for Cesarean Sections
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 350
- Enrollment target
NCT00330278 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 350 participants.
The verdict
NCT00330278, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 350 participants
- Enrollment target
Study Summary
This is a randomized, double-blinded placebo controlled trial of cefazolin timing before cesarean section fo infection prophylaxis. Subjects are randomized to cefazolin either 30 minutes prior to skin incision or at time of cord-clamping. Primary outcome is infectious morbidity including wound infections and endometritis.
Interventions
- DRUG Cefazolin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2003-01 |
| Est. Completion | 2006-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00330278
The ClinicalTrials.gov registry entry for NCT00330278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 350 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cefazolin is the first listed.
NCT00330278 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00330278 about?
NCT00330278 is a clinical study titled "Timing of Prophylactic Antibiotics for Cesarean Sections". This is a randomized, double-blinded placebo controlled trial of cefazolin timing before cesarean section fo infection prophylaxis. Subjects are randomized to cefazolin either 30 minutes prior to skin incision or at time of cord-clamping. Primary outcome is infectious morbidity including wound infec...
What is the current status of trial NCT00330278?
This trial is currently completed. It is a NA study. The enrollment target is 350 participants. The study started on 2003-01. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00330278?
The interventions under investigation include: Cefazolin (DRUG).
Who is sponsoring clinical trial NCT00330278?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.